Sudeep Pharma came to market through an IPO that opened on 21 November 2025 and closed on 25 November 2025, and the shares listed on 28 November 2025 on BSE, NSE. The price band was ₹563 to ₹593 per share and one lot was 25 shares, so the minimum application was ₹14,825. The issue size was ₹895 crore. It combined a fresh issue of new shares with an offer for sale by existing shareholders.
MUFG Intime India Pvt Ltd was the registrar to the issue, and ICICI Securities Ltd., IIFL Capital Services Ltd were the lead managers.
As of 25 November 2025.
| Day |
|---|
| 1 |
| 2 |
| 3 |
Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries.It has six manufacturing facilities that have a combined production capacity of 50,000 MT, manufacturing minerals such as calcium, iron, magnesium, zinc, potassium, and sodium. The company supplies over 200 products to a wide customer base across the pharma, food, and nutrition sectors.The company has strong R&D capabilities comprising in-house labs and pilot-scale facilities for mineral salts and excipients.
Product Portfolio: Pharmaceutical, Food and Nutrition Business Specialty Ingredients Business Triturates As of 31 December 2024, the company had 704 permanent employees.
As described in the offer document.
| Metric | 30-Jun-25 | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 |
|---|
Sudeep Pharma raises over Rs 268 crore via anchor book. Among anchor investors who participated in the IPO anchor book of Sudeep Pharma were SBI Mutual Fund, HDFC AMC, ICICI Prudential MF, Axis Mutual Fund, WhiteOak Capital, Aditya Birla Sun Life AMC, Quant MF, SBI Life Insuance, Bandhan MF, Tata AIA Life Insurance, and Edelweiss.
Sujit Jaysukh Bhayani, Avani Sujit Bhayani, Shanil Sujit Bhayani, Sujeet Jaysukh Bhayani HUF, Riva Resources Private Limited, Bhayani Family Trust. Promoter holding 89.36% before the issue and 76.15% after.
Work out the listing gain for this IPO
If the retail portion is not fully subscribed, every valid application is allotted in full. If it is oversubscribed, SEBI's rules require that as many applicants as possible receive at least one lot, so the shares are allotted by a computerised lottery across all valid applications, one lot each, until the retail portion is exhausted. Applying for more lots does not improve your chance in a lottery; it only increases what you receive if the issue is under-subscribed.
The basis of allotment document, published by the registrar on the allotment date, states the ratio: for example, one applicant in seven received one lot.
Allotment status is published by the registrar on its website, searchable by PAN, application number or demat account, and also on the exchange's website. Allotted shares are credited to the demat account the day before listing, and blocked money for unsuccessful applications is released the same day. The Rupix app can check allotment status by PAN once the registrar publishes it.
Shares list within three working days of the issue closing. On listing day the exchanges run a special pre-open session from nine o'clock, during which orders are collected and an opening price is discovered from them; trading in the share begins after that, usually around ten. The opening price is the listing price that appears on this page once the issue has listed, and the listing gain or loss is the difference between it and the issue price.
For a mainboard issue, the share then trades in the normal way with the exchange's price band for a new listing. For an SME issue, shares trade in lots rather than one at a time, and the market can be thin, so selling on listing day is not always possible at the opening price. Capital gains on shares sold within a year of allotment are short-term and taxed at the short-term rate.
Sudeep Pharma IPO was a ₹895 crore book-built issue, comprising a fresh issue of ₹95 crore and an offer for sale of ₹800 crore. It was priced at ₹563–₹593 per share with a lot size of 25 shares (₹14,825). The IPO was open from November 21 to November 25, 2025 and was subscribed 93.71x. Shares listed on BSE and NSE on November 28, 2025 at ₹730, a 23.1% premium to the issue price of ₹593.
MUFG Intime India Pvt Ltd is the registrar. ICICI Securities Ltd. and IIFL Capital Services Ltd. are the book running lead managers.
The price band of Sudeep Pharma IPO is ₹563 to ₹593 per share.
The lot size of Sudeep Pharma IPO is 25 shares.
The minimum investment for Sudeep Pharma IPO is approximately ₹14,825 based on the upper price band.
The allotment date of Sudeep Pharma IPO is Nov 26, 2025.
Sudeep Pharma IPO's final recorded GMP before listing was ₹110 per share (a 19% premium over the ₹593 upper price band). The shares listed at ₹730. GMP is unofficial and does not forecast or guarantee the actual listing price.
Sudeep Pharma IPO listed on Nov 28, 2025. It was issued at ₹730.0(NSE) and is currently around ₹1109.50 as on 2-Nov-2026 3:30 PM, which is approximately 87.1% versus issue price. The 52-week high is ₹1,378.00.
You can check Sudeep Pharma IPO allotment status on the registrar or stock exchange websites using your PAN or application number after allotment. You can also check the Sudeep Pharma IPO allotment status on Rupix for quick and easy access.
₹563 to ₹593 per share, against a face value of ₹1. Most applicants bid at the cut-off price, the top of the band, so that the application was valid whatever price the issuer finally fixed.
One lot was 25 shares, and every application had to be a whole number of lots. At the top of the band that made the minimum application ₹14,825.
₹14,825, for one lot of 25 shares at the top of the price band. The amount was blocked in the applicant's bank account through ASBA or a UPI mandate while the issue was open, and released on the allotment date to applicants who were not allotted shares.
It opened on 21 November 2025 and closed on 25 November 2025.
The basis of allotment was published on 26 November 2025 by MUFG Intime India Pvt Ltd, and allotted shares were credited to demat accounts before listing.
The shares listed on 28 November 2025 on BSE, NSE.
The issue size was ₹895 crore. The fresh issue was 16,02,024 shares (aggregating up to ₹95 crore). The offer for sale was 1,34,90,726 shares (aggregating up to ₹800 crore).